![](https://investorshub.advfn.com/uicon/315468.png?cb=1473363790)
Thursday, April 15, 2021 6:49:04 PM
"MS Drug under Development (RPI-78M) - ReceptoPharm conducted microarray and histoculture studies and related
analysis of the cells of Multiple Sclerosis patients to ascertain how RPI-78M affected the cells of these patients."
So Deitsch has been claiming to develop RPI-78M for 15 years and there still hasn't been anything done.
Garbage like this is why Deitsch doesn't have any credibility.
IG
Get ready scammers. Hell is coming to breakfast.
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM